Search - tctmd.com

Displaying 1 - 20 of 245

Sort: Relevancy | Date

News Features

Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond

Shelley Wood

December 30, 2016

News Daily News

Noncardiac Surgery May Be Safe Earlier After PCI Than Previously Thought

L.A. McKeown

December 12, 2016

News Daily News

With No RCTs, Propensity-Score Matched Analysis Informs Choice Between Cangrelor and GPIs in the Cath Lab

Yael L. Maxwell

December 06, 2016

News Daily News

Tricky Population of Patients With A-fib Undergoing PCI Tackled in New Consensus Document

Todd Neale

November 29, 2016

News Conference News AHA 2016

Dabigatran Reversal Agent’s Safety, Efficacy Affirmed With Updated Study Results

Todd Neale

November 15, 2016

Presentation TCT 2016

DEBATE: Predicting Thrombotic Events in Patients With STEMI and Multivessel Disease: Vulnerable Plaque Is the Single Most Important Factor!

Presenter: Ran Kornowski, Michel R. Le May, Tej Sheth

October 31, 2016

Presentation TCT 2016

DEBATE: Predicting Thrombotic Events in Patients With STEMI and Multivessel Disease: The Degree of Stenosis/Ischemia Is Most Important!

Presenter: Ran Kornowski, Michel R. Le May, Anthony H. Gershlick

October 31, 2016

Presentation TCT 2016

TCT 7: Relationship Between Traditional Risk Factors, Platelet Reactivity, and Thrombotic Events: A Mediation Analysis From ADAPT-DES

Presenter: Dimitrios Alexopoulos, Laurent Bonello, Bjorn Redfors

October 31, 2016

Presentation TCT 2016

TCT 6: Simultaneous Impact of Thrombotic and Bleeding Risks on Use of Novel P2Y12 Inhibitors in Contemporary PCI: Results From a Large Single-Center Registry

Presenter: Dimitrios Alexopoulos, Laurent Bonello, Usman Baber

October 31, 2016

Presentation TCT 2016

Case 1: Primary PTCA With High Thrombotic Burden: How Did I Treat it?

Presenter: Ricardo Lluberas, Jeffrey W. Moses, Jamil Abdalla Saad, Gustavo S. Vignolo

October 30, 2016

News Conference News TCT 2016

LEADERS FREE: Polymer-Free DES Maintains Superior Safety, Efficacy Over BMS at 2 Years

Yael L. Maxwell

October 30, 2016

News Industry News

Study Confirms Polymer-Free Drug-Coated Stents Safer And More Effective Than Bare-Metal Stents In Patients At Risk For Bleeding Treated With One Month Of DAPT

October 30, 2016

News Daily News

No Differences Between Bivalirudin, Unfractionated Heparin in ACS Patients With or Without ST Elevation: MATRIX

Shelley Wood

October 03, 2016

News Conference News PCR London Valves 2016

Cerebral Protection in TAVR: New Insights, New Questions as First Device Seeks FDA Clearance

Shelley Wood

September 22, 2016

News Daily News

Stroke Risk With TAVR: In-Depth Review of PARTNER and CoreValve Data Reveals Opportunities and Unknowns

Shelley Wood

September 13, 2016

News Industry News

FDA Approves New AGGRASTAT® Product Format

September 01, 2016

News Conference News ESC 2016

Reversal Agent for Factor Xa Inhibitors Rapidly Reduces Anticoagulant Effects: ANNEXA-4

Todd Neale

August 31, 2016

Presentation ESC 2016

Effective Anti-thrombotic Therapy without Stenting: Intravascular OCT-based Management in Plaque Erosion (the EROSION study)

Presenter: Ik-Kyung Jang

August 30, 2016

News Conference News ESC 2016

Use of Antithrombotics Instead of Stents Appears Safe, Reduces Thrombus Burden in Subset of ACS Patients: EROSION

Michael O'Riordan

August 30, 2016

News Conference News ESC 2016

NIPPON: With Nobori Stent, 6 Months of DAPT as Safe and Effective as 18 Months

Michael O'Riordan

August 28, 2016

Advertisement

Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond

Noncardiac Surgery May Be Safe Earlier After PCI Than Previously Thought

With No RCTs, Propensity-Score Matched Analysis Informs Choice Between Cangrelor and GPIs in the Cath Lab

Tricky Population of Patients With A-fib Undergoing PCI Tackled in New Consensus Document

Dabigatran Reversal Agent’s Safety, Efficacy Affirmed With Updated Study Results

DEBATE: Predicting Thrombotic Events in Patients With STEMI and Multivessel Disease: Vulnerable Plaque Is the Single Most Important Factor!

DEBATE: Predicting Thrombotic Events in Patients With STEMI and Multivessel Disease: The Degree of Stenosis/Ischemia Is Most Important!

TCT 7: Relationship Between Traditional Risk Factors, Platelet Reactivity, and Thrombotic Events: A Mediation Analysis From ADAPT-DES

TCT 6: Simultaneous Impact of Thrombotic and Bleeding Risks on Use of Novel P2Y12 Inhibitors in Contemporary PCI: Results From a Large Single-Center Registry

Case 1: Primary PTCA With High Thrombotic Burden: How Did I Treat it?

LEADERS FREE: Polymer-Free DES Maintains Superior Safety, Efficacy Over BMS at 2 Years

Study Confirms Polymer-Free Drug-Coated Stents Safer And More Effective Than Bare-Metal Stents In Patients At Risk For Bleeding Treated With One Month Of DAPT

No Differences Between Bivalirudin, Unfractionated Heparin in ACS Patients With or Without ST Elevation: MATRIX

Cerebral Protection in TAVR: New Insights, New Questions as First Device Seeks FDA Clearance

Stroke Risk With TAVR: In-Depth Review of PARTNER and CoreValve Data Reveals Opportunities and Unknowns

FDA Approves New AGGRASTAT® Product Format

Reversal Agent for Factor Xa Inhibitors Rapidly Reduces Anticoagulant Effects: ANNEXA-4

Effective Anti-thrombotic Therapy without Stenting: Intravascular OCT-based Management in Plaque Erosion (the EROSION study)

Use of Antithrombotics Instead of Stents Appears Safe, Reduces Thrombus Burden in Subset of ACS Patients: EROSION

NIPPON: With Nobori Stent, 6 Months of DAPT as Safe and Effective as 18 Months

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content